The top 10 biopharma stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apellis, Bristol Myers Squibb, Daiichi Sankyo, Incyte, Xortx.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 4D, Aevitas, Blue Water, Cidera, Danco, Fortress, Genbiopro, Genentech, Genmab, Janssen, J&J, Melinta, Navamedic, PDS, Roche, Sensidose, Veru.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Cantargia, Edison Oncology, Elucida Oncology, Janux, Junshi, Oblato.

Biopharmas raising money in public or private financings, including: AB Science, Albert, Applied, Vaxcyte.

New hires and promotions in the biopharma industry, including: Brainstorm Cell, GRI, Harmony, Immunogen, Ipsen, Tarsus.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Uromems.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Active Implants, Aptitude Medical, Aziyo, Beacon Biomedical, Boehringer Ingelheim, Emit Imaging, Lemaitre Vascular, Neracare, Retinai, Skylinedx, Watkins-Conti.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Establishment Labs, Know Labs, Mindpeak, Paragonix Technologies.

New hires and promotions in the med-tech industry, including: Extractx.